相关实验视频

Updated: Jan 16, 2026

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Published on: February 27, 2015

癌症研究中的蛋白质和:从生物标志物到生物疗法

Joo Hyeong Seo¹, Seung Hoon Shin¹, Hye Rin Woo¹

¹Department of Biotechnology and Bioinformatics, Korea University, Sejong 30019, Republic of Korea.

|September 27, 2025

概括

蛋白质和对于癌症诊断和治疗至关重要. 技术的进步正在改善它们在个性化癌症治疗中的使用,克服了稳定性和传递等挑战.

科学领域:

生物化学生物化学
分子生物学分子生物学
在瘤学瘤学.

背景情况:

蛋白质和是癌症进展的组成部分,包括生长,免疫逃避,血管新生和转移.
这些生物分子因其在瘤学中的诊断和治疗潜力而越来越受认可.
目前的研究重点是利用蛋白质和来精确管理癌症.

研究的目的:

提供基于蛋白质和的癌症诊断和治疗策略的全面审查.
突出最近的研究趋势和该领域的技术进步.
讨论这些策略的临床应用,挑战和未来方向.

主要方法:

关于蛋白质和的生物标记物和治疗药物的当前文献的综述.
对诊断标记物的分析 (例如,PSA,CA125,HER2,AFP).
治疗方式的检查 (例如,单克隆抗体,免疫检查点抑制剂,抗癌).
定量分析技术的概述 (例如,ELISA,质谱学,CyTOF).
讨论传递系统 (例如,纳米粒子-化合物) 的进步.

主要成果:

蛋白质和作为癌症的诊断标记物和治疗剂显示出显著的希望.
已建立的标记物如PSA,CA125,HER2和AFP具有临床意义.
像单克隆抗体和免疫检查点抑制剂这样的治疗策略正在进步.
提供高目标特异性和可改性精密疗法,但面临稳定性和交付挑战.
新兴技术正在解决局限性并提高临床适用性.

结论:

基于蛋白质和的策略对精确的癌症诊断和个性化治疗有很大的潜力.
克服稳定性,降解和输送方面的挑战是更广泛的临床采用的关键.
合成生物学,计算设计和奥米克集成分析的持续进步将推动未来的进步.

关键词:

生物标志物生物标志物生物治疗药物生物治疗药物癌症癌症癌症癌症癌症这是一种类.蛋白质蛋白质是蛋白质蛋白质的组成部分.

更多相关视频

Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology

Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology

Published on: March 24, 2015

A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions

A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions

Published on: April 18, 2025

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

Cancer

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Transducer Mechanism: Enzyme-Linked Receptors

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...